Literature DB >> 33067605

Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.

Lasse Folkersen1,2,3, Stefan Gustafsson3,4, Qin Wang3,5,6, Michael V Holmes3,7,8, Erik Ingelsson3,9, Anders Mälarstig10,11,12, Daniel Hvidberg Hansen3,13, Åsa K Hedman1,3,14, Andrew Schork3,15,16, Karen Page3,17, Daria V Zhernakova3,18, Yang Wu3,19, James Peters3,20,21,22, Niclas Eriksson3,23, Sarah E Bergen3,24, Thibaud S Boutin3,25, Andrew D Bretherick3,25, Stefan Enroth3,26, Anette Kalnapenkis3,27,28, Jesper R Gådin1,3, Bianca E Suur3,29, Yan Chen1,3, Ljubica Matic3,29, Jeremy D Gale3,30, Julie Lee3,17, Weidong Zhang3,31, Amira Quazi3,17, Mika Ala-Korpela3,5,6,32, Seung Hoan Choi3,33, Annique Claringbould3,18, John Danesh3,20,21,34,35,36,37, George Davey Smith3,38, Federico de Masi3,13, Sölve Elmståhl3,39, Gunnar Engström3,39, Eric Fauman3,40, Celine Fernandez3,39, Lude Franke3,18, Paul W Franks3,41, Vilmantas Giedraitis3,42, Chris Haley3,25, Anders Hamsten1,3, Andres Ingason3,15, Åsa Johansson3,26, Peter K Joshi3,43, Lars Lind3,44, Cecilia M Lindgren3,33,45,46, Steven Lubitz3,33,47, Tom Palmer3,48, Erin Macdonald-Dunlop3,43, Martin Magnusson3,49,50,51, Olle Melander3,39, Karl Michaelsson3,52, Andrew P Morris3,46,53,54, Reedik Mägi3,27, Michael W Nagle3,40, Peter M Nilsson3,39, Jan Nilsson3,39, Marju Orho-Melander3,55, Ozren Polasek3,56, Bram Prins3,20,21, Erik Pålsson3,57, Ting Qi3,19, Marketa Sjögren3,39, Johan Sundström3,58,59, Praveen Surendran3,20,21,34,60, Urmo Võsa3,27, Thomas Werge3,15, Rasmus Wernersson3,13, Harm-Jan Westra3,18, Jian Yang3,19,61,62, Alexandra Zhernakova3,18, Johan Ärnlöv3,63, Jingyuan Fu3,18,64, J Gustav Smith3,50,65, Tõnu Esko3,27,33, Caroline Hayward3,25, Ulf Gyllensten3,26, Mikael Landen3,57, Agneta Siegbahn3,66, James F Wilson3,25,43, Lars Wallentin3,67, Adam S Butterworth3,20,21,34,35,36.   

Abstract

Circulating proteins are vital in human health and disease and are frequently used as biomarkers for clinical decision-making or as targets for pharmacological intervention. Here, we map and replicate protein quantitative trait loci (pQTL) for 90 cardiovascular proteins in over 30,000 individuals, resulting in 451 pQTLs for 85 proteins. For each protein, we further perform pathway mapping to obtain trans-pQTL gene and regulatory designations. We substantiate these regulatory findings with orthogonal evidence for trans-pQTLs using mouse knockdown experiments (ABCA1 and TRIB1) and clinical trial results (chemokine receptors CCR2 and CCR5), with consistent regulation. Finally, we evaluate known drug targets, and suggest new target candidates or repositioning opportunities using Mendelian randomization. This identifies 11 proteins with causal evidence of involvement in human disease that have not previously been targeted, including EGF, IL-16, PAPPA, SPON1, F3, ADM, CASP-8, CHI3L1, CXCL16, GDF15 and MMP-12. Taken together, these findings demonstrate the utility of large-scale mapping of the genetics of the proteome and provide a resource for future precision studies of circulating proteins in human health.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33067605      PMCID: PMC7611474          DOI: 10.1038/s42255-020-00287-2

Source DB:  PubMed          Journal:  Nat Metab        ISSN: 2522-5812


  42 in total

Review 1.  Therapeutic antibodies: successes, limitations and hopes for the future.

Authors:  Patrick Chames; Marc Van Regenmortel; Etienne Weiss; Daniel Baty
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

Review 2.  Mendelian randomization in cardiometabolic disease: challenges in evaluating causality.

Authors:  Michael V Holmes; Mika Ala-Korpela; George Davey Smith
Journal:  Nat Rev Cardiol       Date:  2017-06-01       Impact factor: 32.419

3.  Co-regulatory networks of human serum proteins link genetics to disease.

Authors:  Valur Emilsson; Marjan Ilkov; John R Lamb; Lori L Jennings; Vilmundur Gudnason; Nancy Finkel; Elias F Gudmundsson; Rebecca Pitts; Heather Hoover; Valborg Gudmundsdottir; Shane R Horman; Thor Aspelund; Le Shu; Vladimir Trifonov; Sigurdur Sigurdsson; Andrei Manolescu; Jun Zhu; Örn Olafsson; Johanna Jakobsdottir; Scott A Lesley; Jeremy To; Jia Zhang; Tamara B Harris; Lenore J Launer; Bin Zhang; Gudny Eiriksdottir; Xia Yang; Anthony P Orth
Journal:  Science       Date:  2018-08-02       Impact factor: 47.728

4.  Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability.

Authors:  Erika Assarsson; Martin Lundberg; Göran Holmquist; Johan Björkesten; Stine Bucht Thorsen; Daniel Ekman; Anna Eriksson; Emma Rennel Dickens; Sandra Ohlsson; Gabriella Edfeldt; Ann-Catrin Andersson; Patrik Lindstedt; Jan Stenvang; Mats Gullberg; Simon Fredriksson
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

5.  Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs.

Authors:  Stefan Enroth; Asa Johansson; Sofia Bosdotter Enroth; Ulf Gyllensten
Journal:  Nat Commun       Date:  2014-08-22       Impact factor: 14.919

6.  Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.

Authors:  Lasse Folkersen; Eric Fauman; Maria Sabater-Lleal; Rona J Strawbridge; Mattias Frånberg; Bengt Sennblad; Damiano Baldassarre; Fabrizio Veglia; Steve E Humphries; Rainer Rauramaa; Ulf de Faire; Andries J Smit; Philippe Giral; Sudhir Kurl; Elmo Mannarino; Stefan Enroth; Åsa Johansson; Sofia Bosdotter Enroth; Stefan Gustafsson; Lars Lind; Cecilia Lindgren; Andrew P Morris; Vilmantas Giedraitis; Angela Silveira; Anders Franco-Cereceda; Elena Tremoli; Ulf Gyllensten; Erik Ingelsson; Søren Brunak; Per Eriksson; Daniel Ziemek; Anders Hamsten; Anders Mälarstig
Journal:  PLoS Genet       Date:  2017-04-03       Impact factor: 5.917

7.  Undulating changes in human plasma proteome profiles across the lifespan.

Authors:  Benoit Lehallier; David Gate; Nicholas Schaum; Tibor Nanasi; Song Eun Lee; Hanadie Yousef; Patricia Moran Losada; Daniela Berdnik; Andreas Keller; Joe Verghese; Sanish Sathyan; Claudio Franceschi; Sofiya Milman; Nir Barzilai; Tony Wyss-Coray
Journal:  Nat Med       Date:  2019-12-05       Impact factor: 53.440

8.  Plasma protein patterns as comprehensive indicators of health.

Authors:  Stephen A Williams; Peter Ganz; Nicholas J Wareham; Mika Kivimaki; Claudia Langenberg; Aroon D Hingorani; J P Casas; Claude Bouchard; Christian Jonasson; Mark A Sarzynski; Martin J Shipley; Leigh Alexander; Jessica Ash; Tim Bauer; Jessica Chadwick; Gargi Datta; Robert Kirk DeLisle; Yolanda Hagar; Michael Hinterberg; Rachel Ostroff; Sophie Weiss
Journal:  Nat Med       Date:  2019-12-02       Impact factor: 53.440

9.  Genomic atlas of the human plasma proteome.

Authors:  Benjamin B Sun; Joseph C Maranville; James E Peters; David Stacey; James R Staley; James Blackshaw; Stephen Burgess; Tao Jiang; Ellie Paige; Praveen Surendran; Clare Oliver-Williams; Mihir A Kamat; Bram P Prins; Sheri K Wilcox; Erik S Zimmerman; An Chi; Narinder Bansal; Sarah L Spain; Angela M Wood; Nicholas W Morrell; John R Bradley; Nebojsa Janjic; David J Roberts; Willem H Ouwehand; John A Todd; Nicole Soranzo; Karsten Suhre; Dirk S Paul; Caroline S Fox; Robert M Plenge; John Danesh; Heiko Runz; Adam S Butterworth
Journal:  Nature       Date:  2018-06-06       Impact factor: 49.962

10.  A genome-wide association study identifies protein quantitative trait loci (pQTLs).

Authors:  David Melzer; John R B Perry; Dena Hernandez; Anna-Maria Corsi; Kara Stevens; Ian Rafferty; Fulvio Lauretani; Anna Murray; J Raphael Gibbs; Giuseppe Paolisso; Sajjad Rafiq; Javier Simon-Sanchez; Hana Lango; Sonja Scholz; Michael N Weedon; Sampath Arepalli; Neil Rice; Nicole Washecka; Alison Hurst; Angela Britton; William Henley; Joyce van de Leemput; Rongling Li; Anne B Newman; Greg Tranah; Tamara Harris; Vijay Panicker; Colin Dayan; Amanda Bennett; Mark I McCarthy; Aimo Ruokonen; Marjo-Riitta Jarvelin; Jack Guralnik; Stefania Bandinelli; Timothy M Frayling; Andrew Singleton; Luigi Ferrucci
Journal:  PLoS Genet       Date:  2008-05-09       Impact factor: 5.917

View more
  55 in total

1.  Large-scale integration of the plasma proteome with genetics and disease.

Authors:  Egil Ferkingstad; Patrick Sulem; Bjarni A Atlason; Gardar Sveinbjornsson; Magnus I Magnusson; Edda L Styrmisdottir; Kristbjorg Gunnarsdottir; Agnar Helgason; Asmundur Oddsson; Bjarni V Halldorsson; Brynjar O Jensson; Florian Zink; Gisli H Halldorsson; Gisli Masson; Gudny A Arnadottir; Hildigunnur Katrinardottir; Kristinn Juliusson; Magnus K Magnusson; Olafur Th Magnusson; Run Fridriksdottir; Saedis Saevarsdottir; Sigurjon A Gudjonsson; Simon N Stacey; Solvi Rognvaldsson; Thjodbjorg Eiriksdottir; Thorunn A Olafsdottir; Valgerdur Steinthorsdottir; Vinicius Tragante; Magnus O Ulfarsson; Hreinn Stefansson; Ingileif Jonsdottir; Hilma Holm; Thorunn Rafnar; Pall Melsted; Jona Saemundsdottir; Gudmundur L Norddahl; Sigrun H Lund; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2021-12-02       Impact factor: 38.330

2.  Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women.

Authors:  Amy E Mendham; Lisa K Micklesfield; Fredrik Karpe; Andre Pascal Kengne; Tinashe Chikowore; Clement N Kufe; Maphoko Masemola; Nigel J Crowther; Shane A Norris; Tommy Olsson; Sölve Elmståhl; Tove Fall; Lars Lind; Julia H Goedecke
Journal:  Diabetologia       Date:  2022-09-17       Impact factor: 10.460

3.  Considerations of biomarker application for cancer continuum in the era of precision medicine.

Authors:  Rayjean J Hung; Elham Khodayari Moez; Shana J Kim; Sanjeev Budhathoki; Jennifer D Brooks
Journal:  Curr Epidemiol Rep       Date:  2022-07-09

4.  Plasma Protein Profile of Carotid Artery Atherosclerosis and Atherosclerotic Outcomes: Meta-Analyses and Mendelian Randomization Analyses.

Authors:  Lars Lind; Bruna Gigante; Yan Borné; Tobias Feldreich; Jerzy Leppert; Pär Hedberg; Carl Johan Östgren; Fredrik H Nyström; Johan Sundström; Johan Ärnlöv; Damiano Baldassarre; Elena Tremoli; Fabrizio Veglia; Anders Hamsten; Christopher J O'Donnell; Nora Franceschini; Marju Orho-Melander; Jan Nilsson; Olle Melander; Gunnar Engström; Anders Mälarstig
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-04       Impact factor: 8.311

Review 5.  Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development.

Authors:  Michael V Holmes; Tom G Richardson; Brian A Ference; Neil M Davies; George Davey Smith
Journal:  Nat Rev Cardiol       Date:  2021-03-11       Impact factor: 32.419

6.  Soluble receptor for advanced glycation end products (sRAGE) and asthma: Mendelian randomisation study.

Authors:  Yoshihiko Raita; Zhaozhong Zhu; Robert J Freishtat; Michimasa Fujiogi; Liming Liang; Jason T Patregnani; Carlos A Camargo; Kohei Hasegawa
Journal:  Pediatr Allergy Immunol       Date:  2021-03-05       Impact factor: 5.464

7.  Proteomic Profiles of Body Mass Index and Waist-to-Hip Ratio and Their Role in Incidence of Diabetes.

Authors:  Xue Bao; Biao Xu; Songjiang Yin; Jingxue Pan; Peter M Nilsson; Jan Nilsson; Olle Melander; Marju Orho-Melander; Gunnar Engström
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

Review 8.  Big Data, Data Science, and Causal Inference: A Primer for Clinicians.

Authors:  Yoshihiko Raita; Carlos A Camargo; Liming Liang; Kohei Hasegawa
Journal:  Front Med (Lausanne)       Date:  2021-07-06

Review 9.  Genetics of Type 2 Diabetes: Opportunities for Precision Medicine: JACC Focus Seminar.

Authors:  Daniel Seung Kim; Anna L Gloyn; Joshua W Knowles
Journal:  J Am Coll Cardiol       Date:  2021-08-03       Impact factor: 27.203

10.  Association of Interleukin-6 Signaling and C-Reactive Protein With Intracranial Aneurysm: A Mendelian Randomization and Genetic Correlation Study.

Authors:  Peng-Peng Niu; Xue Wang; Yu-Ming Xu
Journal:  Front Genet       Date:  2021-06-08       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.